Rare diseases
Investigational molecules
Locations
1 Dna Way, 94080-4918, United States
Genentech Inc. funds a broad oncology portfolio spanning advanced melanoma, non-small cell lung cancer, metastatic breast cancer, colorectal cancer, pancreatic ductal adenocarcinoma, and advanced prostate cancer. Its studies also include HER2-expressing cancers, KRAS G12C-mutated solid tumors, and other locally advanced or metastatic solid tumors.
Research activity also extends to relapsed or refractory multiple myeloma, B-cell malignancies, and other hematologic cancers, alongside solid-tumor programs that target difficult-to-treat metastatic disease.
Genentech Inc. runs clinical trials in conditions such as Breast cancer, Breast cancer metastatic, Hormone receptor positive breast cancer, Colitis ulcerative, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceFrance
Czechia
Germany
BelgiumBelgiumBelgiumBelgiumFranceGermanyGermanyGermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
